Thiocolchicoside

PreclinicalSmall molecule

Sanofi

Thiocolchicoside is one of 15 small molecule programs targeting Myalgia. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

MyalgiaActive, not recruiting

MyalgiaPreclinical

Active, not recruiting

Competition

Competitive Landscape

15 competitors in Myalgia

#DrugCompanyPhaseTrials

Bayer Aspirin

Voltaren

Olumiant

Aleve

Advil

1 6

Ansaid

PPharmacia and Upjohn

Approved

—7

Esmeron

FFresenius Kabi USA, LLC

Approved

—8

Indocin

CCosette Pharmaceuticals, Inc.

Xylocaine

Aspercreme Warming

AAveritas Pharma, Inc.

Approved

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Low back pain2 trials

Efficacy Safety of a Combination Thiocolchicoside+Ketoprofen Compared to Thiocolchicoside Twice a Day for 7 Days in Patients Suffering From Acute Non Specific Low Back Pain

Completed· Sanofi logo

Sanofi·Phase 3·NCT00679146·334 enrolled

Thiocolchicoside Injection and Capsule in Treatment of Acute Low Back Pain

Completed· Sanofi logo

Sanofi·Phase 4·NCT00917436·183 enrolled

Efficacy1 trial

EMINEM: Efficacy of Muscoril In NEck Myofascial Syndromes

Completed· Sanofi logo

Sanofi·Phase 4·NCT00272532·65 enrolled

Myalgia1 trial

Evaluation of the Effects of Treatments Applied to Patients With Facial Myalgia on Occlusion Parameters

Completed·YYuzuncu Yil University·N/A·NCT05261971·60 enrolled

Bruxism1 trial

Short-Term Patient-Reported Symptom Changes Across Clinically Selected Management Pathways in Adults With Bruxism-Related and Temporomandibular Disorder Symptoms: A Prospective Non-Randomized Observational Study

Completed·RRecep Tayyip Erdogan University··NCT07586072·60 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for Thiocolchicoside. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Thiocolchicoside compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Thiocolchicoside. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Sanofi company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: Sanofi

Thiocolchicoside

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Low back pain2 trials

Efficacy1 trial

Myalgia1 trial

Bruxism1 trial

References

Drug Info

Quick Facts

Related News